Golbarg Mohammadi Roozbahani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Golbarg Mohammadi Roozbahani has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Xiaohan Chen
Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences, Chongqing 400714, China
9 shared publications - Xiyun Guan
Department of Chemistry, University of Missouri, Columbia, MO, 65211, USA
9 shared publications - Youwen Zhang
Department of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, Indiana 46556, United States
9 shared publications - Attila Oravecz
Institut de Génétique et de Biologie Moléculaire et Cellulaire, 67404 Illkirch, France
2 shared publications - Carlos Ernesto Castro
The Ohio State University
2 shared publications - Dien Li
Savannah River National Laboratory, Aiken, SC, 29808, USA
2 shared publications
Latest Publications
- Open Access
- 27 April 2026
- Published by Elsevier in SSRN Electronic Journal
Functionality and Tunability of Danuglipron-Containing Matrix Tablets for Extended Drug Delivery
This study examines the development and optimization of matrix tablets containing danuglipron, a GLP-1 receptor agonist, over a wide range of drug loadings and extended drug release rates. Hypromellose was chosen as the release controlling polymer as it enabled tunability. Formulation components and levels were explored which provided optimal manufacturability for active tablet strength ranging from 10 mg to 400 mg. Matrix tablets containing microcrystalline cellulose, colloidal silicon dioxide and magnesium stearate demonstrated optimal tablet hardness, suitable friability and adequate powder flow of the blends with no evidence of tablet punch sticking over the drug loading range. Direct compression was selected as the preferred manufacturing method due to its superior hardness profile and simplicity. Drug release was controlled through a combination of hypromellose type 2208 (100 mPa.s and 4000 mPa.s), while maintaining the total polymer content at 30% w/w in the tablet. This study demonstrates that the ratio of two hypromellose grades can be adjusted to tune the drug release rate to 4 to > 24-hours over 4% to 40% active drug loading range. Mechanistic studies show that tablets both swell and erode when hydrated with higher content of the 4000 mPa.s hypromellose leading to increased swelling, while those with higher 100 mPa.s polymer content resulted in greater erosion. The Korsmeyer–Peppas model was applied to analyze the release kinetics, revealing a combined effect of erosion and diffusion mechanisms for all the formulations studied. The release mechanism was the same regardless of danuglipron drug loading, suggesting the in vivo performance would be consistent for all tablet strengths. The in vitro release study confirmed the effectiveness of the matrix design for a wide range of tablet strengths, showcasing its potential for enhancing the pharmacokinetic profiles for a more convenient once daily (QD) drug delivery system.
- 27 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessFunctionality and Tunability of Danuglipron-Containing Matrix Tablets for Extended Drug Delivery
This study examines the development and optimization of matrix tablets containing danuglipron, a GLP-1 receptor agonist, over a wide range of drug loadings and extended drug release rates. Hypromellose was chosen as the release controlling polymer as it enabled tunability. Formulation components and levels were explored which provided optimal manufacturability for active tablet strength ranging from 10 mg to 400 mg. Matrix tablets containing microcrystalline cellulose, colloidal silicon dioxide and magnesium stearate demonstrated optimal tablet hardness, suitable friability and adequate powder flow of the blends with no evidence of tablet punch sticking over the drug loading range. Direct compression was selected as the preferred manufacturing method due to its superior hardness profile and simplicity. Drug release was controlled through a combination of hypromellose type 2208 (100 mPa.s and 4000 mPa.s), while maintaining the total polymer content at 30% w/w in the tablet. This study demonstrates that the ratio of two hypromellose grades can be adjusted to tune the drug release rate to 4 to > 24-hours over 4% to 40% active drug loading range. Mechanistic studies show that tablets both swell and erode when hydrated with higher content of the 4000 mPa.s hypromellose leading to increased swelling, while those with higher 100 mPa.s polymer content resulted in greater erosion. The Korsmeyer–Peppas model was applied to analyze the release kinetics, revealing a combined effect of erosion and diffusion mechanisms for all the formulations studied. The release mechanism was the same regardless of danuglipron drug loading, suggesting the in vivo performance would be consistent for all tablet strengths. The in vitro release study confirmed the effectiveness of the matrix design for a wide range of tablet strengths, showcasing its potential for enhancing the pharmacokinetic profiles for a more convenient once daily (QD) drug delivery system.
- Open Access
- 5 July 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (27) , eadn9423
Piggybacking functionalized DNA nanostructures into live-cell nuclei
DNA origami nanostructures (DOs) are promising tools for applications including drug delivery, biosensing, detecting biomolecules, and probing chromatin substructures. Targeting these nanodevices to mammalian cell nuclei could provide impactful approaches for probing, visualizing, and controlling biomolecular processes within live cells. We present an approach to deliver DOs into live-cell nuclei. We show that these DOs do not undergo detectable structural degradation in cell culture media or cell extracts for 24 hours. To deliver DOs into the nuclei of human U2OS cells, we conjugated 30-nanometer DO nanorods with an antibody raised against a nuclear factor, specifically the largest subunit of RNA polymerase II (Pol II). We find that DOs remain structurally intact in cells for 24 hours, including inside the nucleus. We demonstrate that electroporated anti–Pol II antibody–conjugated DOs are piggybacked into nuclei and exhibit subdiffusive motion inside the nucleus. Our results establish interfacing DOs with a nuclear factor as an effective method to deliver nanodevices into live-cell nuclei.
- 5 July 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (27) , eadn9423
Open AccessPiggybacking functionalized DNA nanostructures into live-cell nuclei
DNA origami nanostructures (DOs) are promising tools for applications including drug delivery, biosensing, detecting biomolecules, and probing chromatin substructures. Targeting these nanodevices to mammalian cell nuclei could provide impactful approaches for probing, visualizing, and controlling biomolecular processes within live cells. We present an approach to deliver DOs into live-cell nuclei. We show that these DOs do not undergo detectable structural degradation in cell culture media or cell extracts for 24 hours. To deliver DOs into the nuclei of human U2OS cells, we conjugated 30-nanometer DO nanorods with an antibody raised against a nuclear factor, specifically the largest subunit of RNA polymerase II (Pol II). We find that DOs remain structurally intact in cells for 24 hours, including inside the nucleus. We demonstrate that electroporated anti–Pol II antibody–conjugated DOs are piggybacked into nuclei and exhibit subdiffusive motion inside the nucleus. Our results establish interfacing DOs with a nuclear factor as an effective method to deliver nanodevices into live-cell nuclei.
- Open Access
Piggybacking functionalized DNA nanostructures into live cell nuclei
DNA origami (DO) are promising tools for in vitro or in vivo applications including drug delivery; biosensing, detecting biomolecules; and probing chromatin sub-structures. Targeting these nanodevices to mammalian cell nuclei could provide impactful approaches for probing visualizing and controlling important biological processes in live cells. Here we present an approach to deliver DO strucures into live cell nuclei. We show that labelled DOs do not undergo detectable structural degradation in cell culture media or human cell extracts for 24 hr. To deliver DO platforms into the nuclei of human U2OS cells, we conjugated 30 nm long DO nanorods with an antibody raised against the largest subunit of RNA Polymerase II (Pol II), a key enzyme involved in gene transcription. We find that DOs remain structurally intact in cells for 24hr, including within the nucleus. Using fluorescence microscopy we demonstrate that the electroporated anti-Pol II antibody conjugated DOs are efficiently piggybacked into nuclei and exihibit sub-diffusive motion inside the nucleus. Our results reveal that functionalizing DOs with an antibody raised against a nuclear factor is a highly effective method for the delivery of nanodevices into live cell nuclei.
Open AccessPiggybacking functionalized DNA nanostructures into live cell nuclei
DNA origami (DO) are promising tools for in vitro or in vivo applications including drug delivery; biosensing, detecting biomolecules; and probing chromatin sub-structures. Targeting these nanodevices to mammalian cell nuclei could provide impactful approaches for probing visualizing and controlling important biological processes in live cells. Here we present an approach to deliver DO strucures into live cell nuclei. We show that labelled DOs do not undergo detectable structural degradation in cell culture media or human cell extracts for 24 hr. To deliver DO platforms into the nuclei of human U2OS cells, we conjugated 30 nm long DO nanorods with an antibody raised against the largest subunit of RNA Polymerase II (Pol II), a key enzyme involved in gene transcription. We find that DOs remain structurally intact in cells for 24hr, including within the nucleus. Using fluorescence microscopy we demonstrate that the electroporated anti-Pol II antibody conjugated DOs are efficiently piggybacked into nuclei and exihibit sub-diffusive motion inside the nucleus. Our results reveal that functionalizing DOs with an antibody raised against a nuclear factor is a highly effective method for the delivery of nanodevices into live cell nuclei.
- 2 December 2019
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 144 (24) , 7432-7436
Enzymatic reaction-based nanopore detection of zinc ions
We report a label-free nanopore sensor for the detection of Zn2+ ions. By taking advantage of the cleavage of a substrate peptide by zinc-dependent enzymes, nanomolar concentrations of Zn2+ ions could be detected within minutes. Furthermore, structurally similar transition metals such as Ni2+, Co2+, Hg2+, Cu2+, and Cd2+ did not interfere with their detection. The enzymatic reaction-based nanopore sensing strategy developed in this work may find potential applications in environmental monitoring and medical diagnosis.
- 2 December 2019
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 144 (24) , 7432-7436
Enzymatic reaction-based nanopore detection of zinc ions
We report a label-free nanopore sensor for the detection of Zn2+ ions. By taking advantage of the cleavage of a substrate peptide by zinc-dependent enzymes, nanomolar concentrations of Zn2+ ions could be detected within minutes. Furthermore, structurally similar transition metals such as Ni2+, Co2+, Hg2+, Cu2+, and Cd2+ did not interfere with their detection. The enzymatic reaction-based nanopore sensing strategy developed in this work may find potential applications in environmental monitoring and medical diagnosis.
- Open Access
- 11 January 2019
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 144 (5) , 1825-1830
Rapid and sensitive detection of the activity of ADAM17 using a graphene oxide-based fluorescence sensor
The cleavage of the peptide substrate by ADAM17 releases a dye-labelled short peptide fragment into the solution, thus producing fluorescence.
- 11 January 2019
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 144 (5) , 1825-1830
Open AccessRapid and sensitive detection of the activity of ADAM17 using a graphene oxide-based fluorescence sensor
The cleavage of the peptide substrate by ADAM17 releases a dye-labelled short peptide fragment into the solution, thus producing fluorescence.
- 24 December 2018
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 2 (1) , 504-509
Salt-Mediated Nanopore Detection of ADAM-17
ADAM-17 (a disintegrin and metalloproteinase 17) plays an important role in various physiological and pathophysiological processes. Overexpression/underexpression of ADAM-17 could lead to various diseases. In this work, by taking advantage of ionic strength and salt gradient, and monitoring the enzymatic cleavage reaction between a substrate peptide and ADAM-17 in a nanopore, we developed a label-free sensor for the rapid detection of ADAM-17. The sensor was highly sensitive and selective: picomolar concentrations of ADAM-17 could be detected within minutes, while structure similar proteases such as ADAM-9 and MMP-9 did not interfere with its detection. Given the importance of MMPs/ADAMs as valuable biomarkers and potential therapeutic targets for the early detection and treatment of human cancers, the nanopore-based protease detection strategy developed in this work may find potential applications in disease diagnosis and drug screening.
- 24 December 2018
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 2 (1) , 504-509
Salt-Mediated Nanopore Detection of ADAM-17
ADAM-17 (a disintegrin and metalloproteinase 17) plays an important role in various physiological and pathophysiological processes. Overexpression/underexpression of ADAM-17 could lead to various diseases. In this work, by taking advantage of ionic strength and salt gradient, and monitoring the enzymatic cleavage reaction between a substrate peptide and ADAM-17 in a nanopore, we developed a label-free sensor for the rapid detection of ADAM-17. The sensor was highly sensitive and selective: picomolar concentrations of ADAM-17 could be detected within minutes, while structure similar proteases such as ADAM-9 and MMP-9 did not interfere with its detection. Given the importance of MMPs/ADAMs as valuable biomarkers and potential therapeutic targets for the early detection and treatment of human cancers, the nanopore-based protease detection strategy developed in this work may find potential applications in disease diagnosis and drug screening.
- 19 November 2018
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 54 (99) , 13977-13980
Displacement chemistry-based nanopore analysis of nucleic acids in complicated matrices
The matrix effect on nanopore stochastic sensing of nucleic acids could be overcome by taking advantage of displacement chemical reaction.
- 19 November 2018
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 54 (99) , 13977-13980
Displacement chemistry-based nanopore analysis of nucleic acids in complicated matrices
The matrix effect on nanopore stochastic sensing of nucleic acids could be overcome by taking advantage of displacement chemical reaction.
- 2 August 2018
- Published by Wiley in Electrophoresis
- Vol. 39 (19) , 2410-2416
Nanopore label‐free detection of single‐nucleotide deletion in Baxα/BaxΔ2
Baxα, a key tumor suppressor gene, will not be expressed correctly as a result of single nucleotide mutation in its microsatellite region; Instead, BaxΔ2, an isoform of Baxα, is often produced. In addition, lack of the exon 2 due to an alternative splicing, BaxΔ2 has the same sequence as Baxα except single base deletion from eight continuous guanines (G8) to G7. Most of the currently available methods for Bax∆2 detection are inefficient and time‐consuming, and/or require the use of labels or dyes. In this work, we reported a label‐free nanopore sensing strategy to differentiate between Baxα and BaxΔ2 with a DNA polymer as a molecular probe based on alternative spliced sequences. Two DNA molecules were designed to selectively detect Baxα and BaxΔ2, respectively. The method was rapid, accurate, and highly sensitive: picomolar concentrations of target nucleic acids could be detected in minutes. Our developed simple and fast nanopore‐based detection strategy is not only useful for distinguishing between Baxα and Bax∆2, but also provides a useful tool for detection of other single‐base mutations in genetic diagnosis.
- 2 August 2018
- Published by Wiley in Electrophoresis
- Vol. 39 (19) , 2410-2416
Nanopore label‐free detection of single‐nucleotide deletion in Baxα/BaxΔ2
Baxα, a key tumor suppressor gene, will not be expressed correctly as a result of single nucleotide mutation in its microsatellite region; Instead, BaxΔ2, an isoform of Baxα, is often produced. In addition, lack of the exon 2 due to an alternative splicing, BaxΔ2 has the same sequence as Baxα except single base deletion from eight continuous guanines (G8) to G7. Most of the currently available methods for Bax∆2 detection are inefficient and time‐consuming, and/or require the use of labels or dyes. In this work, we reported a label‐free nanopore sensing strategy to differentiate between Baxα and BaxΔ2 with a DNA polymer as a molecular probe based on alternative spliced sequences. Two DNA molecules were designed to selectively detect Baxα and BaxΔ2, respectively. The method was rapid, accurate, and highly sensitive: picomolar concentrations of target nucleic acids could be detected in minutes. Our developed simple and fast nanopore‐based detection strategy is not only useful for distinguishing between Baxα and Bax∆2, but also provides a useful tool for detection of other single‐base mutations in genetic diagnosis.
- 2 July 2018
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 410 (24) , 6177-6185
Graphene oxide-based biosensing platform for rapid and sensitive detection of HIV-1 protease
HIV-1 protease is essential for the life cycle of the human immunodeficiency virus (HIV), and is one of the most important clinical targets for antiretroviral therapies. In this work, we developed a graphene oxide (GO)-based fluorescence biosensing platform for the rapid, sensitive, and accurate detection of HIV-1 protease, in which fluorescent-labeled HIV-1 protease substrate peptide molecules were covalently linked to GO. In the absence of HIV-1 protease, fluorescein was effectively quenched by GO. In contrast, in the presence of HIV-1 protease, it would cleave the substrate peptide into short fragments, thus producing fluorescence. Based on this sensing strategy, HIV-1 protease could be detected at as low as 1.18 ng/mL. More importantly, the sensor could successfully detect HIV-1 protease in human serum. Such GO-based fluorescent sensors may find useful applications in many fields, including diagnosis of protease-related diseases, as well as sensitive and high-throughput screening of drug candidates.
- 2 July 2018
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 410 (24) , 6177-6185
Graphene oxide-based biosensing platform for rapid and sensitive detection of HIV-1 protease
HIV-1 protease is essential for the life cycle of the human immunodeficiency virus (HIV), and is one of the most important clinical targets for antiretroviral therapies. In this work, we developed a graphene oxide (GO)-based fluorescence biosensing platform for the rapid, sensitive, and accurate detection of HIV-1 protease, in which fluorescent-labeled HIV-1 protease substrate peptide molecules were covalently linked to GO. In the absence of HIV-1 protease, fluorescein was effectively quenched by GO. In contrast, in the presence of HIV-1 protease, it would cleave the substrate peptide into short fragments, thus producing fluorescence. Based on this sensing strategy, HIV-1 protease could be detected at as low as 1.18 ng/mL. More importantly, the sensor could successfully detect HIV-1 protease in human serum. Such GO-based fluorescent sensors may find useful applications in many fields, including diagnosis of protease-related diseases, as well as sensitive and high-throughput screening of drug candidates.
- 12 April 2018
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 90 (9) , 5938-5944
Computation-Assisted Nanopore Detection of Thorium Ions
Thorium is a well-known radioactive and chemically toxic contaminant in the environment. The continuous exposure to thorium may cause an increased risk of developing lung and liver diseases as well as lung, pancreas, and bone cancer. Due to its use in nuclear industry and other industrial applications, thorium may be accidentally released to the environment from its mining and processing plants. In this work, we developed a rapid, real-time, and label-free nanopore sensor for Th4+ detection by using an aspartic acid containing peptide as a chelating agent and tuning the electrolyte solution pH to control the net charges of the peptide ligand and its metal ion complex. The method is highly sensitive with a detection limit of 0.45 nM. Furthermore, the sensor is selective: other metal ions (e.g., UO22+, Pb2+, Cu2+, Ni2+, Hg2+, Zn2+, As3+, Mg2+, and Ca2+) with concentrations of up to 3 orders of magnitude greater than that of Th4+ would not interfere with Th4+detection. In addition, simulated water samples were successfully analyzed. Our developed computation-assisted sensing strategy should find useful applications in the development of nanopore sensors for other metal ions.
- 12 April 2018
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 90 (9) , 5938-5944
Computation-Assisted Nanopore Detection of Thorium Ions
Thorium is a well-known radioactive and chemically toxic contaminant in the environment. The continuous exposure to thorium may cause an increased risk of developing lung and liver diseases as well as lung, pancreas, and bone cancer. Due to its use in nuclear industry and other industrial applications, thorium may be accidentally released to the environment from its mining and processing plants. In this work, we developed a rapid, real-time, and label-free nanopore sensor for Th4+ detection by using an aspartic acid containing peptide as a chelating agent and tuning the electrolyte solution pH to control the net charges of the peptide ligand and its metal ion complex. The method is highly sensitive with a detection limit of 0.45 nM. Furthermore, the sensor is selective: other metal ions (e.g., UO22+, Pb2+, Cu2+, Ni2+, Hg2+, Zn2+, As3+, Mg2+, and Ca2+) with concentrations of up to 3 orders of magnitude greater than that of Th4+ would not interfere with Th4+detection. In addition, simulated water samples were successfully analyzed. Our developed computation-assisted sensing strategy should find useful applications in the development of nanopore sensors for other metal ions.